The following statement is being issued by Levi & Korsinsky, LLP:

To: All Persons or Entities who purchased Nexvet Biopharma Public Limited Company (NASDAQ: NVET) stock  prior to April 13, 2017 .

You are hereby notified that a complaint has been filed in the USDC for the Northern District of California concerning the  fairness of the sale of Nexvet to a subsidiary of Zoetis Inc. for $6.72 per share in cash. To learn more about the action and your rights,  go to:

http://www.zlkdocs.com/NVET-Info-Request-Form-ma-5850

or contact Joseph E. Levi, Esq. either via email at  jlevi@levikorsinsky.com or by telephone at (212) 363-7500, toll-free: (877) 363-5972.  There is no cost or obligation to you.

Levi & Korsinsky is a national firm with offices in New York, Connecticut, California, and Washington D.C. The firm's attorneys have extensive expertise in prosecuting securities litigation involving financial fraud, representing investors throughout the nation in securities lawsuits and have  recovered hundreds of millions of dollars for aggrieved shareholders. For more information, please feel free to contact any of the attorneys listed below. Attorney advertising. Prior results do not guarantee similar outcomes.

View source version on businesswire.com: http://www.businesswire.com/news/home/20170602005546/en/

Copyright Business Wire 2010